Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
22.82x2.52x-0.91x4.44x14.61x16.49x-.--% 1.61TCr
28.75x5.65x0.64x7.55x22.58x23.2x-.--% 5.07TCr
18x3.47x-2.09x5.52x12.07x13.92x1.65% 4.86TCr
-17.95x1.05x2.93x3.48x-6.34x-4.9x-.--% 2.36TCr
-38.59x60.22x0.66x12.9x-34.98x-40.83x-.--% 2.25TCr
21.67x2.13x1.53x4.28x11.11x13.38x-.--% 1.75TCr
817.74x11.85x-7.35x19.27x105.56x221.46x-.--% 1.54TCr
-15.63x70.85x0.87x4112.17x-19.09x-16.34x-.--% 1.45TCr
-452.98x18.52x9.54x32.5x-2035.42x-319.92x-.--% 1.34TCr
15.74x4.45x1.16x4.52x10.59x11.66x-.--% 1.25TCr
-72.8x25.49x1.55x7.3x-68.89x-53.66x-.--% 1.15TCr
-25.43x21.39x-0x21.01x-29.65x-23.52x-.--% 1.1TCr
-11.49x-10.67x14.36x90.59x-11.91x-11.8x-.--% 927.77Cr
13.35x6.7x0.03x8.07x13.32x13.93x-.--% 909.02Cr
31.04x5.07x-2.48x7x27.25x31.08x - 872.14Cr
-9.71x - -0.08x - - - - 849.4Cr
35.26x6.7x0.75x10.19x25.86x26.62x0.24% 835.29Cr
-18.51x8.13x5.37x652.3x-18.42x-17.06x-.--% 825.92Cr
-6.34x - -0.12x - -6.5x-5.98x-.--% 779.6Cr
107.21x2.17x-1.88x4.34x21.56x47.05x0.14% 663.23Cr
Average 22.11x 13.65x 1.22x 278.19x -103.51x -3.96x 0.11% 1.62TCr
Weighted average by Cap. 25.39x 13.32x 0.72x 222.18x -80.05x 0.40x 0.27%
Bio Therapeutic Drugs